Zhongzhi Pharmaceutical Holdings Limited (3737.HK) HKSE
0.84
+0.02(+2.44%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.84
+0.02(+2.44%)
Currency In HKD
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2577
First IPO Date
July 13, 2015
| Name | Title | Pay | Year Born |
| Xiao Jun Cao | Deputy GM & Executive Director | 1.73M | 1968 |
| Ying Feng Lai | Chief Executive & Executive Director | 2.78M | 1992 |
| Ying Sheng Lai | Chief Financial Officer & Executive Director | 2.89M | 1994 |
| Zhi Tian Lai | Executive Chairman | 3.33M | 1968 |
| Wing Yan | Company Secretary | 0 | 1982 |
Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company operates through three segments: Pharmaceutical Manufacturing, Operation of Chain Pharmacies, and Operation of On-Line Pharmacies. It provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brands. The company is also manufacture and sale of food and Chinese herbs; property management; and pharmaceutical drugs, as well as offers detection and testing services. As of December 31, 2021, it operated 398 self-operated chain pharmacies, including 361 medical insurance designated pharmacies located in Zhongshan in the Guangdong Province under the Zeus brand. The company was founded in 1993 and is headquartered in Zhongshan, the People's Republic of China. Zhongzhi Pharmaceutical Holdings Limited is a subsidiary of Crystal Talent Investment Group Limited.